Ionis Pharmaceuticals in (ions 1.75 06/15/28)
13F holders, Q3 2024 (September 30)3holders −1
1new positions
2sold out
$1.03avg. 13F price*
At the end of Q3 2024, 3 institutions reported holding Ionis Pharmaceuticals in (ions 1.75 06/15/28) in their 13F filings, down 1 from Q2 2024. 1 opened new positions and 2 sold out. The largest holders were BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.6M), Sei Investments Co. ($271K) and Bank of New York Mellon Corp ($262K).
- Company
- Ionis Pharmaceuticals in (ions 1.75 06/15/28)
- CUSIP
- 462222AF7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $271K |
| Exits | 2 | $26.1M |
All 13F filers, Q2 2024 → Q3 2024: 262,000 shares bought and 23,817,000 shares sold, net −23,555,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 2,500,000 | $2.6M |
| Sei Investments Co. | 0.00% | New | 262,000 | $271K |
| Bank of New York Mellon Corp | 0.00% | No change | 250,000 | $262K |
"% of holder's portfolio" is IONIS PHARMACEUTICALS IN (IONS 1.75 06/15/28)'s weight in each manager's 13F, not the share of Ionis Pharmaceuticals in (ions 1.75 06/15/28) the manager owns.